{
  "docId": "019de513-c80e-76c4-bed6-836ae224a0a1",
  "docSlug": "9176cd0c899293b6954f3c95d2d2a6c0",
  "documentTitle": "Core Scientific | Results Presentation Deck | 20 slides",
  "authorId": "core-scientific",
  "authorName": "Core Scientific",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-08-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 4,
  "pageCount": 20,
  "prevPage": 3,
  "nextPage": 5,
  "slideType": "kpi_overview",
  "function": "summarize",
  "density": "dense",
  "nDataPoints": 14,
  "notes": null,
  "elementsJson": null,
  "metadataConfidence": 0.9,
  "imagePath": null,
  "slideHref": "/slides/019de513-c80e-76c4-bed6-836ae224a0a1/4",
  "deckHref": "/decks/019de513-c80e-76c4-bed6-836ae224a0a1",
  "deckJsonHref": "/decks/019de513-c80e-76c4-bed6-836ae224a0a1.json",
  "deckAnchorHref": "/decks/019de513-c80e-76c4-bed6-836ae224a0a1#slide-4",
  "components": [
    {
      "bbox": {
        "h": 0.05,
        "w": 0.93,
        "x": 0.03,
        "y": 0.87
      },
      "kind": "source-note",
      "text": "1 Adjusted EBITDA is a non-GAAP financial measure. See slide 19 for a reconciliation of adjusted EBITDA to its most comparable GAAP figure.\n2 Adjusted earnings per diluted share is a non-GAAP financial measure. See slide 20 for a reconciliation of adjusted earnings (loss) per diluted share to its most comparable GAAP figure.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "274295b0-7691-42f7-84eb-163532241481",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.66,
        "w": 0.94,
        "x": 0.03,
        "y": 0.17
      },
      "kind": "table",
      "text": "Metric (dollars in millions except per share amounts) | Second Quarter 2022 | Notes\nTotal ending hashrate | 17.9 EH/s | 10% increase from 3/31/22 (16.2 EH/s)\nBitcoins produced | 3,365 | Increased from 3,202 bitcoins in first quarter\nBitcoins held | 1,959 | $40.7 million carrying value as of 6/30/22, including effect of accounting impairment\nRevenue | $164.0 | 118% increase over prior year\nNet loss | $(861.7) | $858.3 million increase in loss over prior year\nAdjusted EBITDA 1 | $59.1 | 185% increase over prior year\nLoss per diluted share | $(2.65) | —\nAdjusted earnings per diluted share 2 | $0.18 | 38% increase over prior year",
      "attrs": null,
      "subkind": "data",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c6c9cf1c-37ca-4c18-87dc-edc1862173bc",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.75,
        "x": 0.03,
        "y": 0.06
      },
      "kind": "title",
      "text": "Second Quarter 2022 Performance Summary",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "7e0cb95e-a718-4ad5-b3bb-e63b4fd2db66",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 4,
      "from": 3,
      "beatId": "35ce5889-5a1e-4f13-9f2b-1160bfc14dfc",
      "arcName": "Monroe's Motivated Sequence",
      "arcSlug": "monroes-sequence",
      "beatName": "Need",
      "beatSlug": "monroes-sequence-need",
      "evidence": "The presentation highlights Core Scientific's current financial and operational status, outlining the need for improvement",
      "position": 1,
      "confidence": 0.8,
      "parentBeatName": "Complication",
      "parentBeatSlug": "complication"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}